Herbert Smith Freehills Kramer advises underwriters on QingSong Health’s Hong Kong IPO

Leading global law firm Herbert Smith Freehills Kramer has advised China International Capital Corporation Hong Kong Securities Limited and China Merchants Securities (HK) Co., Limited as underwriters on QingSong Health Corporation (02661.HK)’s listing on the Main Board of the Hong Kong Stock Exchange.

“This transaction marks a strong finish to a standout year for our Hong Kong IPO practice,” said Hong Kong partner Matt Emsley. “With a robust listing pipeline ahead, we are ready to carry this momentum into 2026.”

QingSong Health provides healthcare and insurance solutions, including digital marketing, digital medical research, integrated health service packages and consultancy on early disease screening, alongside insurance brokerage and technical services.

“We congratulate QingSong Health on its successful Hong Kong listing,” said Beijing partner Stanley Xie. “We are proud to have supported this milestone.”

Partners Matt Emsley, Stanley Xie and Jin Kong* led a cross-office team advising the underwriters, supported by Jaime Fong, Bryan Ge, Crystal Chan, Bryan Zhu, Wang Ting, Leah Zhi, Allen Wang, Angel Lau and Hugo Leung.

Legal manager Marine Jin led Herbert Smith Freehills Kewei Joint Operation’s Digital Legal Delivery business to provide high-efficiency solutions for verification and other document-intensive processes during the listing, assisted by Jean Zhou, Chloe Hu, Mia Jin and Yichen Cai.

*Due to regulatory requirements in Hong Kong, Jin Kong’s official title is Senior Registered Foreign Lawyer.